CCL
Carnival Corporation & plc
CCL has the edge over GME overall, supported by stronger modeled upside and lower modeled downside.
GME
GameStop Corp.
GME offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CCL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
CCL's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
GME Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Unavailable |
GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.
CCL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $24.05 | -18% |
| Forward | 12x | $29.34 | — |
| Current | 13x | $29.34 | — |
| Fair | 14x | $32.52 | +11% |
| Expensive | 21x | $48.32 | +65% |
Historical ranges are pointers, not guarantees.
CCL's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
GME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 17x | $25.62 | — |
| Cheap | 18x | $27.96 | +9.1% |
| Forward | 38x | $25.62 | — |
| Fair | 43x | $66.84 | +161% |
| Expensive | 252x | $388 | +1414% |
Historical ranges are pointers, not guarantees.
GME has the edge over CCL in the historical PE scenario, which offers more potential upside but is not a forecast.
CCL Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
CCL has the edge over GME on the outlook, with more favorable valuation and earnings expectations.
GME Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Strong decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect GME's earnings and revenue to decline, with profitability weakening.
CCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.39 | +3.3% |
| Q3 2026 | $2.31 | +17% |
| Q2 2026 | $2.24 | +18% |
| Q1 2026 | $2.27 | +46% |
| Q4 2025 | $2.02 | +40% |
| Q3 2025 | $1.97 | +67% |
| Q2 2025 | $1.90 | +168% |
| Q1 2025 | $1.55 | +384% |
| Q4 2024 | $1.44 | +$1.50 |
CCL's earnings per share have fallen from their peak: $2.31 over the past year, against $4.32 in late 2019.
GME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.67 | -56% |
| Q3 2026 | $1.54 | +93% |
| Q2 2026 | $1.34 | +153% |
| Q1 2026 | $0.77 | +133% |
| Q4 2025 | $0.89 | +394% |
| Q3 2025 | $0.80 | +515% |
| Q2 2025 | $0.53 | +563% |
| Q1 2025 | $0.33 | +1550% |
| Q4 2024 | $0.18 | +$0.21 |
GME's earnings per share have climbed steadily: $1.54 over the past year, up 93% from the year before, and higher year over year for 15 quarters in a row.
CCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.4B | +3.5% |
| Q2 2026 | $6.7B | +5.3% |
| Q1 2026 | $6.2B | +6.1% |
| Q4 2025 | $6.3B | +6.6% |
| Q3 2025 | $8.2B | +3.3% |
| Q2 2025 | $6.3B | +9.5% |
| Q1 2025 | $5.8B | +7.5% |
| Q4 2024 | $5.9B | +10% |
CCL has the edge over GME on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | -1.5 points |
| Q2 2026 | 13% | -2 points |
| Q1 2026 | 9.8% | +0.5 points |
| Q4 2025 | 12% | +2.2 points |
| Q3 2025 | 28% | +0.3 points |
| Q2 2025 | 15% | +5.1 points |
| Q1 2025 | 9.3% | +4.2 points |
| Q4 2024 | 9.4% | +2.3 points |
CCL has the edge over GME on profitability, with a higher operating margin.
GME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $790.2M | -19% |
| Q2 2026 | $835.3M | +14% |
| Q1 2026 | $1.1B | -14% |
| Q4 2025 | $821M | -4.6% |
| Q3 2025 | $972.2M | +22% |
| Q2 2025 | $732.4M | -17% |
| Q1 2025 | $1.3B | -28% |
| Q4 2024 | $860.3M | -20% |
GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +13 points |
| Q2 2026 | 17% | +19 points |
| Q1 2026 | 12% | +6 points |
| Q4 2025 | 5% | +8.9 points |
| Q3 2025 | 6.8% | +9.6 points |
| Q2 2025 | -1.5% | +4.3 points |
| Q1 2025 | 6.2% | +3.1 points |
| Q4 2024 | -3.9% | -2.5 points |
GME's operating margin was 20% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2019.
CCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $712M | -3.3% |
| Q2 2026 | $1.8B | +14% |
| Q1 2026 | $697M | +119% |
| Q4 2025 | $12M | -96% |
| Q3 2025 | $736M | +17% |
| Q2 2025 | $1.5B | +114% |
| Q1 2025 | $318M | +$688M |
| Q4 2024 | $319M | +29% |
CCL generated $3.2B in free cash flow over the past year, up 9% from the year before.
GME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | -46% |
| Q2 2026 | $332.9M | +76% |
| Q1 2026 | $187.4M | +18% |
| Q4 2025 | $107M | +435% |
| Q3 2025 | $113.3M | +73% |
| Q2 2025 | $189.6M | +$304.3M |
| Q1 2025 | $158.8M | +$177.5M |
| Q4 2024 | $20M | +80% |
GME has the edge over CCL on cash flow, with more consistent year-over-year improvement.
CCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -20M shares |
| 1 year | -2.4% | -34M shares |
| 3 years | -2% | -28M shares |
| 5 years | +21% | +236M shares |
| Available history | +100% | +684M shares |
CCL has the edge over GME on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $548M |
| Q4 2021 | $94M |
| Q3 2021 | $94M |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
GME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +300K shares |
| 1 year | +8.4% | +46.1M shares |
| 3 years | +94% | +288M shares |
| 5 years | +104% | +302M shares |
| Available history | +80% | +264M shares |
GME has 593M diluted shares, up 8.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q1 2020 | $21.8M |
| Q4 2019 | $114M |
CCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.1x | Elevated |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 4.1x | High |
| Q4 2024 | 4.3x | High |
CCL's net debt is about 3.1 years of its operating earnings (EBITDA), down from 3.5 years a year ago.
GME Net Leverage
CCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.6 | Neutral |
| Stochastic | 80.8 | Overbought |
CCL's weekly RSI is 59 (neutral) and its Stochastic is 81 (overbought).
GME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 68.5 | Neutral |
GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).
CCL PE vs Consumer Cyclical Sector
| Metric | CCL | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 30% below |
| PE % | 39 | 47 | 8 pts below |
CCL has the edge over GME on valuation relative to its sector.
GME PE vs Consumer Cyclical Sector
| Metric | GME | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 7.7% below |
| PE % | 15 | 47 | 32 pts below |
GME is trading at 17x earnings, in line with the Consumer Cyclical sector's median of 18x.
CCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.8 | 9.6% above |
| 20 week MA | $26.3 | 12% above |
| 50 week MA | $27.5 | 6.6% above |
| 100 week MA | $26.6 | 11% above |
| 200 week MA | $21.1 | 39% above |
CCL is in an uptrend: it's above all five of its weekly moving averages, and 39% above its 200-week average.
GME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.2 | 1.8% above |
| 20 week MA | $22.4 | 15% above |
| 50 week MA | $22.6 | 13% above |
| 100 week MA | $24.0 | 7% above |
| 200 week MA | $21.8 | 17% above |
GME is in an uptrend: it's above all five of its weekly moving averages, and 17% above its 200-week average.
CCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.3 | $20.8 | -59% |
| 2021 | $20.8 | $21.2 | +1.7% |
| 2022 | $21.2 | $7.81 | -63% |
| 2023 | $7.81 | $18.5 | +137% |
| 2024 | $18.5 | $25.1 | +35% |
| 2025 | $25.1 | $30.7 | +22% |
| 2026 YTD | $30.7 | $29.3 | -4.4% |
CCL's yearly returns have swung widely, from +137% in 2023 to −63% in 2022. It's down 4.4% so far in 2026.
GME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.48 | $5.04 | +241% |
| 2021 | $5.04 | $38.0 | +655% |
| 2022 | $38.0 | $20.1 | -47% |
| 2023 | $20.1 | $17.5 | -13% |
| 2024 | $17.5 | $32.2 | +84% |
| 2025 | $32.2 | $21.1 | -35% |
| 2026 YTD | $21.1 | $25.6 | +21% |
GME has the edge over CCL on returns for 2026, with the stronger performance.